FCER2 - Fc epsilon receptor II Gene
Also Known as CD23; FCE2; CD23A; IGEBF; CLEC4J; FCErII; BLAST-2
Species: Homo sapiens
About FCER2
This gene has 7 transcripts (splice variants), 861 orthologues and 14 paralogues. Biased expression in spleen (RPKM 20.9), lymph node (RPKM 16.3) and 4 other tissues.
Summary
The protein encoded by this gene is a B-cell specific antigen, and a low-affinity receptor for IgE. It has essential roles in B cell growth and differentiation, and the regulation of IgE production. This protein also exists as a soluble secreted form, then functioning as a potent mitogenic growth factor. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Jul 2011]
FCER2 Products (3)
| mRNA | Protein | Name |
|---|---|---|
| NM_001207019.3 | NP_001193948.2 | low affinity immunoglobulin epsilon Fc receptor isoform b |
| NM_001220500.2 | NP_001207429.1 | low affinity immunoglobulin epsilon Fc receptor isoform a |
| NM_002002.5 | NP_001993.2 | low affinity immunoglobulin epsilon Fc receptor isoform a |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables IgE binding |
IDA
IDA: Inferred from direct assay
|
16172256 | GOA |
| enables low-affinity IgE receptor activity |
IDA
IDA: Inferred from direct assay
|
7544003 | GOA |
| enables protease binding |
IPI
IPI: Inferred from physical interaction
|
12777399 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
16172256 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in B cell antigen processing and presentation |
IDA
IDA: Inferred from direct assay
|
2167225 | GOA |
| involved in Fc receptor-mediated immune complex endocytosis |
IDA
IDA: Inferred from direct assay
|
2167225 | GOA |
| involved in macrophage activation |
IDA
IDA: Inferred from direct assay
|
7544003 | GOA |
| involved in positive regulation of killing of cells of another organism |
IDA
IDA: Inferred from direct assay
|
7544003 | GOA |
| involved in positive regulation of nitric-oxide synthase activity |
IDA
IDA: Inferred from direct assay
|
7544003 | GOA |
| involved in positive regulation of nitric-oxide synthase biosynthetic process |
IDA
IDA: Inferred from direct assay
|
7544003 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in plasma membrane |
IDA
IDA: Inferred from direct assay
|
7544003 | GOA |
FCER2 Protein Structure
Lectin_C: Lectin C-type domain (182 - 283)
- 0
- 100
- 200
- 300
- 321 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
low affinity immunoglobulin epsilon Fc receptor |
|
FCER2 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
FCER2 | P06734 | ATF7 | Homo sapiens | P17544 | 25416956 | |
|
Intra
|
FCER2 | P06734 | ATF7 | Homo sapiens | P17544 | 25416956 | |
|
Intra
|
FCER2 | P06734 | ATF7 | Homo sapiens | P17544 | 25416956 |
Recombinant FCER2 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P72748 | CD23/Fc epsilon RII Protein, Human (HEK293, His) | P06734 (D48-S321) | ≥ 95%, as determined by reducing SDS-PAGE. |
FCER2 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P81551 | CD23 Antibody (YA1296) | IHC-P, ICC/IF, FC | Human |
| HY-P84977 | CD23 Antibody (YA4669) | ELISA, FC | Human |
| HY-P85973 | CD23 Antibody (YA5665) | IHC-P, ICC/IF, ELISA | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Extrinsic Allergic Alveolitis |
|
|
| Chronic Conjunctivitis |
|
|
| Intrinsic Asthma |
|
|
| Leukemia, Chronic Lymphocytic 2 |
|
|
| Cutaneous Leishmaniasis |
|
|
| Urticaria |
|
|
| Allergic Rhinitis |
|
|
| Follicular Lymphoma |
|
|
| Allergic Disease |
|
|
| Rhinitis |
|
|
| Bullous Pemphigoid |
|
|
| Onchocerciasis |
|
|
| Dermatitis, Atopic |
|
|
| Asthma |
|
|
| Chronic Spontaneous Urticaria |
|
|
| Leukemia, Chronic Lymphocytic |
|
|
| Castleman Disease |
|
|
| Prolymphocytic Leukemia |
|
|
| B-Cell Lymphoma |
|
|
| B-Cell Expansion With Nfkb And T-Cell Anergy |
|
|
| Dermatitis |
|
|
| Chronic Urticaria |
|
|
| Combined Immunodeficiency |
|
|
| Malaria |
|
|
| Burkitt Lymphoma |
|
|
| Dyskeratosis Congenita |
|
|
| Chronic Asthma |
|
|
| Lymphoma, Non-Hodgkin, Familial |
|
|
| Skin Disease |
|
|
| Systemic Lupus Erythematosus |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Canis familiaris | FCER2 | VGNC | VGNC:49895 |
| Rattus norvegicus | FCER2 | RGD | RGD:619997 |
| Bos taurus | FCER2 | VGNC | VGNC:28932 |
| Felis catus | FCER2 | VGNC | VGNC:82429 |
| Mus musculus | FCER2 | MGD | MGI:95497 |
| Others | FCER2 | NCBI |